MKKGY - Exscientia climbs as Merck KGaA joins AI drug discovery
2023-09-20 07:47:47 ET
More on Exscientia and AI drug discovery
- Seeking Alpha’s Quant Rating on Exscientia
- Exscientia Is Worth The AI-Driven Speculation
- Exscientia gains as enrollments begin for cancer trial
- AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley
- Recursion stock soars on $50M Nvidia investment, boosts peers (update)
For further details see:
Exscientia climbs as Merck KGaA joins AI drug discovery